Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Singer

Showing results (491-500 of 649) with videos related to

Pageof 65
Sort By:
Journal of Translational Medicine|October 8, 2024
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccineViktoria Knöbl, Lukas Maier, Stefan Grasl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast CancerChristian F Singer, Yen Y Tan, Florian Fitzal, et al.
British Journal of Cancer|October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsP Dubsky, J C Brase, R Jakesz, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2018
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendationsChristian F Singer, Judith Balmaña, Nicole Bürki, et al.
Virchows Archiv : an International Journal of Pathology|May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimensKristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
The Lancet. Psychiatry|February 18, 2022
Gambling disorder in the UK: key research priorities and the urgent need for independent research fundingHenrietta Bowden-Jones, Roxanne W Hook, Jon E Grant, et al.
British Journal of Cancer|October 27, 2012
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriersJ Iqbal, A Ragone, J Lubinski, et al.
Frontiers in Oncology|July 8, 2025
Part I: consensus statements and expert recommendations for <i>HER2</i>-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessmentSoo Chin Lee, Yeon Hee Park, Christian F Singer, et al.
Gynecologic Oncology|October 4, 2020
Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Jeanna M McCuaig, et al.
Breast (Edinburgh, Scotland)|November 6, 2025
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, et al.
Pageof 65

Showing results (491-500 of 649) with videos related to

Sort By:
Pageof 65
Journal of Translational Medicine|October 8, 2024
Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccineViktoria Knöbl, Lukas Maier, Stefan Grasl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast CancerChristian F Singer, Yen Y Tan, Florian Fitzal, et al.
British Journal of Cancer|October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsP Dubsky, J C Brase, R Jakesz, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2018
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendationsChristian F Singer, Judith Balmaña, Nicole Bürki, et al.
Virchows Archiv : an International Journal of Pathology|May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimensKristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
The Lancet. Psychiatry|February 18, 2022
Gambling disorder in the UK: key research priorities and the urgent need for independent research fundingHenrietta Bowden-Jones, Roxanne W Hook, Jon E Grant, et al.
British Journal of Cancer|October 27, 2012
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriersJ Iqbal, A Ragone, J Lubinski, et al.
Frontiers in Oncology|July 8, 2025
Part I: consensus statements and expert recommendations for <i>HER2</i>-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessmentSoo Chin Lee, Yeon Hee Park, Christian F Singer, et al.
Gynecologic Oncology|October 4, 2020
Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Jeanna M McCuaig, et al.
Breast (Edinburgh, Scotland)|November 6, 2025
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, et al.
Pageof 65